The use of eschar swabs for the diagnosis of African tick-bite fever
. Ticks Tick Borne Dis 2012;3(5):361-363.
africae and African tick-bite fever
have not previously been reported in Senegal, and few positive human serum samples have been documented in western Africa.
The patient was treated with doxycycline 200 mg/day for 1 week for suspected African tick-bite fever. Follow-up showed a quick recovery from his symptoms except for fatigue that persisted for [approximately equal to] 1 month.
africae and confirmed the diagnosis of African tick-bite fever.
The geographic distribution of African tick-bite fever is related to the presence of Amblyomma spp.
African tick-bite fever (ATBF), a recently rediscovered rickettsiosis of the spotted fever group, is caused by Rickettsia africae, an obligate intracellular, gram-negative, rod-shaped bacterium, transmitted by cattle ticks of the Amblyomma genus (1-5).
African tick-bite fever: a new spotted fever group rickettsiosis under an old name.
African tick-bite fever: an imported spotless rickettsiosis.
Rickettsia africae is a recently described spotted fever group (SFG) rickettsia that is the agent of African tick-bite fever
(ATBF), a mild but common tickborne disease of local persons and tourists, in particular, in sub-Saharan Africa.
The estimated incidence of African tick-bite fever
in safari travelers is 4%-5.3% (4) but higher incidence may be reported as emphasized in our study.
To date, African tick-bite fever
has been characterized as a mild illness.
africae, has been identified as the agent of African tick-bite fever
. In 2002, the first case report of a patient infected with R.